Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy


YANIK ODABAŞ Ö., Batioglu F., YALÇINDAĞ F. N., DEMİREL S., ÖZMERT E.

Turkish journal of ophthalmology, cilt.52, sa.2, ss.147-152, 2022 (Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 52 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.4274/tjo.galenos.2022.93213
  • Dergi Adı: Turkish journal of ophthalmology
  • Derginin Tarandığı İndeksler: Scopus
  • Sayfa Sayıları: ss.147-152
  • Anahtar Kelimeler: Atypical central serous choriorecinopachy, indocyanine green angiography, photodynamic therapy, eplerenone, VARIANT
  • Ankara Üniversitesi Adresli: Evet

Özet

The aim of this case report is to describe a case of atypical central serous choriorecinopathy (CSCR) definitively diagnosed after 8 years. A 44-year-old woman presented with reduced visual acuity in her left eye. Her visual acuity was light perception with projection in the right eye and 0.15 in the left. She described a similar decline in vision in her right eye 8 years ago. At that time, she had exudative retinal detachment and was created with systemic immunosuppressive therapy for a presumed diagnosis of Vogc-Koyanagi-Harada disease. Despite resolution of the exudative retinal detachment, macular scarring developed. Eight years later, she developed inferior exudative retinal detachment in the left eye. A diagnosis of atypical CSCR was made with the help of multimodal imaging and her left eye was successfully treated with eplerenone and half-fluence photodynamic therapy (hf-PDT). In conclusion, early diagnosis and treatment of atypical CSCR may prevent subretinal fibrosis formation and permanent vision loss. Hf-PDT and eplerenone are successful treatment options for atypical CSCR.